Is there value in a combination study for RC16 and oHSV? ¶
By: Jason E. Barkeloo on March 22, 2017, 8:02 p.m.
Is there value in an in vivo RC16 and oHSV therapy study?
Jason E. Barkeloo
Chairman & Founder, Open Therapeutics
Is there value in a combination study for RC16 and oHSV?
By: Li Guo on March 23, 2017, 7:41 p.m.
The combination of RC16 and oHSV has never been evaluated. Since they each active by different mechanisms, they may synergize and provide better anti-tumor efficacy. An initial exploratory study will be needed to support the value for further combination studies.